Results

Total Results: 601 records

Showing results for "cardiac".
Users also searched for: ekg

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/preoperative-testing_executive.pdf
    January 01, 2014 - A single RCT with low risk of bias failed to find differences in rates of perioperative death or cardiac … planned (as opposed to “minor” or “standard” surgeries), particularly in patients undergoing thoracic, cardiac … Other than increases in vagal tone, there is little reason to expect cardiac strain in the typical patient … planned (as opposed to “minor” or “standard” surgeries), particularly in patients undergoing thoracic, cardiac
  2. Obesity (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
    July 01, 2013 - Among 2472 patients evaluated at 1 year and 1127 evaluated at 2 years, the rate of cardiac 17 … cardiovascular outcomes trial (CVOT) to assess the effects of the drug on the risk of major adverse cardiac … fenfluramine and dexfenfluramine), were withdrawn from the market because of their association with cardiac … fenfluramine and dexfenfluramine, were withdrawn from the market because of their association with cardiac … However, data from at least one study suggests lorcaserin may not increase cardiac valvular disease
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - as a proxy the average cost of new and novel cardiac valves or devices that entered the U.S. market … presenting cardiology research X X X X X X X 36 European Society of Cardiology’s (ESC) Acute Cardiac … Care 1, 11 Annual meeting presenting research on treatments of acute cardiac conditions X X X … X X X X 37 Heart Rhythm Society (HRS) 1, 11 Annual meeting presenting research on cardiac rhythm … Society for Cardiovascular Angiography and Interventions (SCAI) 1, 11 Annual meeting covering cardiac
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
    September 01, 2015 - as a proxy the average cost of new and novel cardiac valves or devices that entered the U.S. market … presenting cardiology research X X X X X X X 36 European Society of Cardiology’s (ESC) Acute Cardiac … Care 1, 11 Annual meeting presenting research on treatments of acute cardiac conditions X X X … X X X X 37 Heart Rhythm Society (HRS) 1, 11 Annual meeting presenting research on cardiac rhythm … Society for Cardiovascular Angiography and Interventions (SCAI) 1, 11 Annual meeting covering cardiac
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
    August 01, 2012 - the help of an eight-person Key Informant group representing clinicians (cardiology, primary care, cardiac … Literature flow diagram 19 baseline clinical characteristics (e.g., age, diabetes, sex, individual cardiac … clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac … there a gender difference in risk profile, attendance, and beneficial effects of a multidisciplinary cardiacCardiac syndrome X. In: Wenger NK and Collins P, eds. Women and heart disease. 2nd ed.
  6. effectivehealthcare-admin.ahrq.gov/products/infantile-hemangioma/research-protocol
    December 01, 2019 - congenital anomalies such as PHACES (posterior fossa malformations, hemangiomas, arterial anomalies, cardiac … airway obstruction Preservation of vision Preservation of organ function (e.g., thyroid function, cardiac … imperforate anus, and skin tag PHACES: Posterior fossa malformations–hemangiomas–arterial anomalies–cardiac
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - enzyme.13 This enzyme is involved in the oxidative metabolism of many synthetic drugs,14-20 including cardiac … how the review will differentiate between varying effects of drug-supplement combinations, as most cardiac … Herbal therapies and cardiac side effects. Prog Cardiovasc Nurs 2008;23:187-90. 17.
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
    January 01, 2022 - treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 (95% CI 0.47 to 0.77) Cardiac
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
    January 01, 2022 - treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 (95% CI 0.47 to 0.77) Cardiac
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/mmm-draft-protocol-amendment.pdf
    February 02, 2022 - factors (hypertension, diabetes, hyperlipidemia, tobacco use, obesity, physical inactivity) ● Cardiac … Near-miss maternal mortality: cardiac dysfunction as the principal cause of obstetric intensive care
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
    January 01, 2014 - presence of either ST segment depression or T-wave inversion on electrocardiography and/or abnormal cardiac … NSTEMI is broadly classified as upstream if the therapy is initiated after admission but prior to cardiac … consists of an oral antiplatelet agent or intravenous (IV) GPI as initial therapy prior to going to the cardiac … Intravenous GPI (select one) – Eptifibatide – Tirofiban – Abciximab Cardiac … , with greater use of conservative, medically managed approaches in countries with less access to cardiac
  12. effectivehealthcare-admin.ahrq.gov/products/prioritization-patient-safety-practices
    January 01, 2024 - quality improvement rather than a safety intervention Beta-Blockers and Reduction of Perioperative Cardiac
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-surgical-report-cards.pdf
    July 01, 2023 - The New York State cardiac registries: history, contributions, limitations, and lessons for future efforts
  14. effectivehealthcare-admin.ahrq.gov/products/mhs4-surgical-report-cards/protocol
    September 01, 2023 - The New York State cardiac registries: history, contributions, limitations, and lessons for future efforts
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-prevalence_research.pdf
    February 01, 2011 - diabetes are expected to suffer from several associ- ated medical complications, such as renal disease, cardiac
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/binge-eating_clinician.pdf
    May 01, 2016 - Avoid use in patients with known structural cardiac abnormalities, cardiomyopathy, serious heart arrhythmia
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
    August 16, 2016 - 3 indications for renal intervention: 1 renovascular hypertension; 2 ischemic nephropathy; and 3 cardiac … improvement in uncontrolled HTN, preservation or salvage of kidney function, prevention or treatment of cardiac … or severity of CHF following medical or interventional therapy for RAS in patients with unstable cardiac
  18. effectivehealthcare-admin.ahrq.gov/products/COVID-19-pharmaceutical-treatments/rapid-research
    March 01, 2024 - per kg RR 0.17; CI 0.01, 4.14 Low   Stone, 2020 0/161 1/82 8 mg per kg RR 0.17; CI 0.01, 4.15 Low Cardiac … 0.56, 1.33 Low   Thompson, 2021 16/143 47/823 Not reported RR 1.96; CI 1.14, 3.36* Moderate/Unclear Cardiac
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
    January 01, 2019 - meta-analysis 2007 BMJ 17426275 Corticosteroids for the prevention of atrial fibrillation after cardiac … Ann Intern Med 20194233 Cost-effectiveness of preparticipation screening for prevention of sudden cardiac … effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac … 2007 Int J Technol Assess Health Care 17999842 The clinical effectiveness and cost-effectiveness of cardiac
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/nonopioid-chronic-pain-apf2_0.xlsx
    January 01, 2018 - Tricyclic Antidepressants - Placebo-Controlled Trials WAE WAE SAE SAE Cardiac Rhythm Abnormalities … Cardiac Rhythm Abnormalities Cardiac Rhythm Abnormalities Cardiac Rhythm Abnormalities Cognitive Effects

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: